Sperm Oxidative Stress and Pregnancy Success During IUI and IVF
NCT ID: NCT03539874
Last Updated: 2024-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
250 participants
OBSERVATIONAL
2023-11-01
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Control Ovarian Stimulation Timing Test
NCT02397135
A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment
NCT02534857
Effect of Reducing the Oxygen Concentration From 5% to 2% on ICSI Outcome
NCT05924048
Oocyte Cryopreservation: Evaluation of an Oocyte Freezing and Thawing Technique
NCT00713869
Association Between Oxidative Parameters in Fertilization Medium of Cumulus Oocyte Complex and Outcome in IVF
NCT03382002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Confirmed paternity
Sperm sample from men with confirmed paternity
No interventions assigned to this group
Intrauterine insemination
Sperm sample from men in intrauterine insemination process
No interventions assigned to this group
In vitro fertilization
Sperm sample from men in in vitro fertilization process
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients aged 18 to 40 using IVF or their first cycle of IUI at the Fertilys Reproductive Health Center, agreeing to participate in the study and having signed the consent form.
Exclusion Criteria
* Men who can not produce a sperm sample by anterograde ejaculation.
* Men going to the Fertilys Reproductive Health Center for a post-vasectomy spermogram.
* Couples who have already completed IUI cycles.
* Couples using gamete donation (eggs or sperm).
* Men with a mobile sperm concentration of less than 5 millions/mL after preparation of the sperm sample during the IUI process.
18 Years
40 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fertilys
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie-Claire Bélanger, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fertilys
Laval, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Cécile Adam, PhD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fabien Joao, M.Sc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.